CLINICAL_TRIALS
trial_result
· 2018-12-19
Clinical Trial Update: Study of APD421 as PONV Treatment (no Prior Prophylaxis) [Phase 3]
Summary
Phase 3 clinical trial results for APD421 as a treatment for postoperative nausea and vomiting have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2018-12-19